Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Efficacy and Safety of Alpha1H Unveiled in Final Phase 2 NMIBC Report

Summary by targetedonc.com
A phase 2 trial shows Hamlet BioPharma's alpha1H is safe and effective in treating NMIBC. It reduces tumor size by 59% with no adverse effects.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

curetoday.comcuretoday.com

Bladder Cancer Drug Alpha1H Shows Benefit in Phase 2 Trial

Alpha1H shows benefit in non-muscle invasive bladder cancer, shrinking tumors and boosting the immune system with manageable side effects.

Read Full Article
targetedonc.comtargetedonc.com

Efficacy and Safety of Alpha1H Unveiled in Final Phase 2 NMIBC Report

A phase 2 trial shows Hamlet BioPharma's alpha1H is safe and effective in treating NMIBC. It reduces tumor size by 59% with no adverse effects.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

targetedonc.com broke the news in on Friday, August 22, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

News
For You
SearchBlindspotLocal